ATHENS, GA, Dalan Animal Health, a pioneering bioscience company, announced the successful closure of a $3 million SAFE (Simple Agreement for Future Equity) funding round.
Dalan Animal Health, the pioneering bioscience company that developed the world's first vaccine for invertebrates, announced the successful closure of a $3 million SAFE (Simple Agreement for Future Equity) funding round. The round included Good Growth Capital together with Meach Cove Capital and other global investors, marking increased international recognition of Dalan's breakthrough Innate Immunity Platform technology.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
